Meet our trust and foundation partners

The ongoing support of our Trust and Foundation partners is helping us make great strides towards a cure for childhood cancer.

The Anthony Rothe Memorial Trust have provided grant funding to Children’s Cancer Institute to support research into the causes, prevention, treatment and cure of leukemia and lymphoma.

The Apex Foundationhelped found Children’s Cancer Institute in 1984 with a $1 million donation to establish its first laboratories. The Apex Foundation provides generous annual grants for our research and supports our Histone Modification Group.

The Bright Blue Charity for Sick Children is supporting a new research initiative into neuroblastoma, focused on uncovering why this aggressive type of cancer occurs in children.


Cure Brain Cancer Foundation is the largest dedicated fundraiser for brain cancer research in Australia. The Foundation funds research programs at Children’s Cancer Institute that focus on finding more effective, less invasive new ways to treat the childhood brain cancer.


The Cure Starts Now  (TCSN) Australian chapter was founded in honour of brave Amy Pedersen, who fell victim to a devastating incurable brain tumour called diffuse intrinsic pontine glioma or DIPG. TCSN is a cancer charity dedicated to a “holistic cure”, funding research at Children’s Cancer Institute to discover innovative new treatments for DIPG.

The Estate of the Late RT Hall generously funds our Tumour Biology & Targeting Program, which is focused on better understanding the role and function of key proteins in cancer cells.


The Kids’ Cancer Project is a leading national charity funding childhood cancer research that funds scientific research at Children’s Cancer Institute to help children with many types of cancer.  It is committed to 100% survival for children with cancer while minimising the potential harmful effects of treatment.

The Live for Lily Foundation fundraise in memory of Lily Hester who lost her battle with childhood cancer in 2013, to support the delivery of the national Zero Childhood Cancer personalised medicine program being led by Children’s Cancer Institute.

The Olivia Lambert Foundation, now wound up, transferred all residual funds to support a Research Team Leader at Children’s Cancer Institute, in memory of courageous Olivia Lambert who tragically passed away from aggressive neuroblastoma after a brave six-year battle. This funding will allow the Research Team Leader to explore newer safer methods of drug delivery in honour of Olivia.

The Profield Foundation is a long-term partner that provides funding to establish a unique drug discovery program aimed at developing better and safer drugs for childhood cancer – in particular, neuroblastoma.


The RCD Foundation supports brain matters in the areas of cancer research, care and development in memory of the ‘awesome’ Robert ‘Connor’ Dawes. After Connor lost a 16-month battle to ependymoma, the fund was created to keep his ‘Aeternum Fortis’ (eternal strength) spirit alive.

The Reuben Pelerman Benevolent Foundation funds our Minimal Residual Disease (MRD) Group, which focuses on examining acute lymphoblastic leukaemia (ALL) samples using advanced molecular diagnostic techniques.

The Tenix Foundation generously supports our goal of identifying, characterising and developing new molecules that will specifically target the abnormal mixed lineage leukaemia (MLL) gene that is responsible for MLL leukaemia, in order to develop a successful drug for this aggressive cancer.

Tour De Cure raise vital funds to support the doctors and scientists who have dedicated their lives to uncovering a cure. Since 2007, Tour de Cure have funded hundreds of cancer projects including some exceptionally talented scientists and brilliant childhood cancer researchers here at Children’s Cancer Institute.